Report: NHS faces over £1 billion loss as 85 biologics go off-patent in five years
The NHS is on track to miss out on savings of over a billion pounds as patents for a new lineup of 85 biologics...
BGMA Warns of significant implications from crippling VPAS rate
The British Generic Manufacturers Association (BGMA) has warned of the significant implications for future supply as a result of the crippling VPAS rate.
The warning...
Current VPAS rate is threat to billions of pound of NHS savings; BGMA proposes reform
The British Generic Manufacturers Association (BGMA) has published a positioning paper which sets out the objectives that need to be delivered through the next...